356 related articles for article (PubMed ID: 7992843)
1. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.
Pierce GF; Tarpley JE; Allman RM; Goode PS; Serdar CM; Morris B; Mustoe TA; Vande Berg J
Am J Pathol; 1994 Dec; 145(6):1399-410. PubMed ID: 7992843
[TBL] [Abstract][Full Text] [Related]
2. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.
Pierce GF; Tarpley JE; Tseng J; Bready J; Chang D; Kenney WC; Rudolph R; Robson MC; Vande Berg J; Reid P
J Clin Invest; 1995 Sep; 96(3):1336-50. PubMed ID: 7657809
[TBL] [Abstract][Full Text] [Related]
3. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
Mustoe TA; Cutler NR; Allman RM; Goode PS; Deuel TF; Prause JA; Bear M; Serdar CM; Pierce GF
Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers.
Robson MC; Phillips LG; Thomason A; Altrock BW; Pence PC; Heggers JP; Johnston AF; McHugh TP; Anthony MS; Robson LE
Ann Plast Surg; 1992 Sep; 29(3):193-201. PubMed ID: 1524367
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
Robson MC; Phillips LG; Thomason A; Robson LE; Pierce GF
Lancet; 1992 Jan; 339(8784):23-5. PubMed ID: 1345953
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
Pierce GF; Tarpley JE; Yanagihara D; Mustoe TA; Fox GM; Thomason A
Am J Pathol; 1992 Jun; 140(6):1375-88. PubMed ID: 1376557
[TBL] [Abstract][Full Text] [Related]
7. Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor.
Danilenko DM; Ring BD; Tarpley JE; Morris B; Van GY; Morawiecki A; Callahan W; Goldenberg M; Hershenson S; Pierce GF
Am J Pathol; 1995 Nov; 147(5):1261-77. PubMed ID: 7485390
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent.
Agren MS; Steenfos HH; Dabelsteen S; Hansen JB; Dabelsteen E
J Invest Dermatol; 1999 Apr; 112(4):463-9. PubMed ID: 10201530
[TBL] [Abstract][Full Text] [Related]
9. Treatment of avascular ulcers with cytokine-induced tissue generation and skin grafting.
Brown DM; Chung SH; Pasia EN; Khouri RK
Am J Surg; 1996 Feb; 171(2):247-50. PubMed ID: 8619461
[TBL] [Abstract][Full Text] [Related]
10. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins.
Pierce GF; Mustoe TA; Senior RM; Reed J; Griffin GL; Thomason A; Deuel TF
J Exp Med; 1988 Mar; 167(3):974-87. PubMed ID: 3280728
[TBL] [Abstract][Full Text] [Related]
11. PDGF and FGF stimulate wound healing in the genetically diabetic mouse.
Greenhalgh DG; Sprugel KH; Murray MJ; Ross R
Am J Pathol; 1990 Jun; 136(6):1235-46. PubMed ID: 2356856
[TBL] [Abstract][Full Text] [Related]
12. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
Rees RS; Robson MC; Smiell JM; Perry BH
Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects.
Marden LJ; Fan RS; Pierce GF; Reddi AH; Hollinger JO
J Clin Invest; 1993 Dec; 92(6):2897-905. PubMed ID: 8254045
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
Kallianinen LK; Hirshberg J; Marchant B; Rees RS
Plast Reconstr Surg; 2000 Nov; 106(6):1243-8. PubMed ID: 11083552
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy.
Pierce GF; Brown D; Mustoe TA
J Lab Clin Med; 1991 May; 117(5):373-82. PubMed ID: 2019792
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds.
Pierce GF; Vande Berg J; Rudolph R; Tarpley J; Mustoe TA
Am J Pathol; 1991 Mar; 138(3):629-46. PubMed ID: 2000940
[TBL] [Abstract][Full Text] [Related]
17. Original articles: ease of wound closure as an endpoint of treatment efficacy.
Robson MC; Maggi SP; Smith PD; Wassermann RJ; Mosiello GC; Hill DP; Cooper DM
Wound Repair Regen; 1999; 7(2):90-6. PubMed ID: 10231510
[TBL] [Abstract][Full Text] [Related]
18. The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.
Mandracchia VJ; Sanders SM; Frerichs JA
Clin Podiatr Med Surg; 2001 Jan; 18(1):189-209, viii. PubMed ID: 11344978
[TBL] [Abstract][Full Text] [Related]
19. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.
Fu X; Shen Z; Chen Y; Xie J; Guo Z; Zhang M; Sheng Z
Chin Med J (Engl); 2000 Apr; 113(4):367-71. PubMed ID: 11775238
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression.
Tkalcević VI; Cuzić S; Brajsa K; Mildner B; Bokulić A; Situm K; Perović D; Glojnarić I; Parnham MJ
Eur J Pharmacol; 2007 Sep; 570(1-3):212-21. PubMed ID: 17628536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
